Biolayer interferometry-based detection of engineered extracellular vesicles binding to type I collagen
Analytical Biochemistry · 2026-09 · 716 · 116162
DOI: 10.1016/j.ab.2026.116162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2026-09. Verfasst von Yan-Jing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Core Facility of West China Hospital, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Extracellular Matrix, Collagen Type I. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Engineered extracellular vesicles (EVs) have garnered significant attention due to their potential serving as both therapeutic agents and drug delivery vehicles. Real-time monitoring of engineered EVs-target interactions constitutes a critical need for advancing EVs-based therapeutics. Here, we present a novel biolayer interferometry (BLI)-based analytical platform for detecting dynamic interactions between collagen-binding domain (CBD)-engineered EVs and type I collagen (Col I). A stable CD63-CBD fusion protein-expressing mouse tendon cell line (designated TT-D6sCBD cells) was initially established using a lentiviral transduction system. Engineered EVs (TT-D6sCBDEVs) were subsequently isolated through optimized differential ultracentrifugation. Col I was covalently immobilized on AR2G biosensors for detecting EVs binding using BLI technology. Quantitative analysis revealed that TT-D6sCBDEVs-treated biosensors demonstrated significantly enhanced BLI signals versus control group (TT-D6sVecEVs), along with time-dependent signal accumulation. Correlative microscopy validation-including scanning electron microscopy (SEM) and confocal microscopy imaging-confirmed the enhanced EVs binding capacity in the test group compared to controls. This work establishes a paradigmatic methodology for characterizing binding kinetics between engineered EVs and their molecular targets, offering critical technical support for advancing precision EVs-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Core Facility of West China Hospital, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China.
- Department of Orthopedic Surgery and Orthopedic Research Institute, Stem Cell and Tissue Engineering Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Core Facility of West China Hospital, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, China. Electronic address: wusisi@wchscu.cn.
Zitieren
APA
Zhang, Y. J., Wang, Y., Chen, X., Yu, S., Yang, J., Cheng, L., Cui, J., & Wu, S. (2026). Biolayer interferometry-based detection of engineered extracellular vesicles binding to type I collagen. Analytical Biochemistry, 716, 116162. https://doi.org/10.1016/j.ab.2026.116162
Vancouver
Zhang YJ, Wang Y, Chen X, Yu S, Yang J, Cheng L, et al. Biolayer interferometry-based detection of engineered extracellular vesicles binding to type I collagen. Analytical Biochemistry. 2026;716:116162. doi:10.1016/j.ab.2026.116162
BibTeX
@article{Zhang2026,
author = {Zhang, Yan-Jing and Wang, Yinchan and Chen, Xuemei and Yu, Shuaishuai and Yang, Jingyuan and Cheng, Lin and Cui, Jing and Wu, Sisi},
title = {Biolayer interferometry-based detection of engineered extracellular vesicles binding to type I collagen},
journal = {Analytical Biochemistry},
year = {2026},
volume = {716},
pages = {116162},
doi = {10.1016/j.ab.2026.116162}
}
EUVIMED